![Jürg Pfister](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jürg Pfister
Fondateur chez Theron Pharmaceuticals, Inc.
Profil
Jürg Pfister is the founder and currently holds the position of Director at Theron Pharmaceuticals, Inc., which was founded in 2008.
Dr. Pfister's former job titles include Director-Chemical Process Development at CV Therapeutics, Inc., Vice President-Medical Chemistry at ARYx Therapeutics, Inc., Senior Researcher at CoMentis, Inc., Principal at Syntex, Inc., and Senior Research Scientist at Roche Bioscience.
Dr. Pfister obtained a doctorate degree from the Swiss Federal Institute of Technology.
Postes actifs de Jürg Pfister
Sociétés | Poste | Début |
---|---|---|
Theron Pharmaceuticals, Inc.
![]() Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Fondateur | 01/01/2008 |
Anciens postes connus de Jürg Pfister
Sociétés | Poste | Fin |
---|---|---|
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Corporate Officer/Principal | - |
Syntex, Inc. | Corporate Officer/Principal | - |
ARYX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Roche Bioscience
![]() Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Directeur Technique/Scientifique/R&D | - |
CoMentis, Inc.
![]() CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Jürg Pfister
Swiss Federal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ARYX THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Theron Pharmaceuticals, Inc.
![]() Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Health Technology |
CoMentis, Inc.
![]() CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Syntex, Inc. | Miscellaneous |
Roche Bioscience
![]() Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Health Technology |